Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AvantorWBO:AVTR -2.36%58 OCF Margin % is 10.53% as of Jun. 2026, which is 3% below its 10-year median of 10.89. GuruFocus rates WBO:AVTR with a GF Score™ of 58/100 and a GF Value™ of €14.60 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Avantor ranks better than 56% on this metric.
The historical rank and industry rank for Avantor's OCF Margin % or its related term are showing as below:
WBO:AVTR'
s OCF Margin % Range Over the Past 10 Years
Min: -13.43 Med: 10.89 Max: 14.54
Current: 9.09
During the past 10 years, the highest OCF Margin % of Avantor was 14.54%. The lowest was -13.43%. And the median was 10.89%.
WBO:AVTR's OCF Margin % is ranked better than 56% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 5.745
vs WBO:AVTR: 9.09
The historical data trend for Avantor's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:AVTR vs RGEN, ATR, TFX: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Avantor's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avantor OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avantor's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Avantor's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avantor (WBO:AVTR) has a OCF Margin % of 10.53% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Avantor and its competitors. This is near median its historical median of 10.89. According to the industry distribution chart, Avantor ranks #359 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 44%.
Is Avantor's OCF Margin % too high?
Avantor's current OCF Margin % of 10.53% is near median its 10-year median of 10.89. The Medical Devices & Instruments industry median OCF Margin % is 5.75. Avantor's value of 10.53% is 83.3% above this industry median. Based on the distribution chart, Avantor ranks #359 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Avantor has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Avantor's OCF Margin % compare to RGEN and ATR?
According to the Medical Devices & Instruments industry distribution chart, Avantor ranks #359 out of 816 companies for OCF Margin %. This puts Avantor in the upper half of its industry. The industry median OCF Margin % is 5.75. Avantor's value of 10.53% is 83.3% above this benchmark. While the company's 10-year median is 10.89 vs. the industry median of 5.75, Avantor has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.75, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avantor's current OCF Margin % of 10.53% is 83.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Avantor and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avantor's current OCF Margin % is 10.53%, which is near median its own 10-year median of 10.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avantor stock overvalued right now?
Based on GuruFocus' analysis, Avantor (WBO:AVTR) is currently considered Modestly Undervalued. The stock's GF Value™ is €14.60, compared to a current price of €11.81 — trading 19.1% below its estimated fair value. The current OCF Margin % is 10.53%, which is near median its 10-year median of 10.89 and 83.3% above the Medical Devices & Instruments industry median of 5.75. Avantor's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Avantor (WBO:AVTR), the current OCF Margin % is 10.53% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avantor (WBO:AVTR) Overvalued in 2026?
Based on GuruFocus' analysis, Avantor stock appears to be undervalued.
The current stock price of €11.81 is trading 19.1% below its estimated GF Value™ of €14.60.
GuruFocus considers Avantor to be Modestly Undervalued.
Key valuation signals for WBO:AVTR:
OCF Margin %: 10.53% (near median its 10-year median of 10.89)
GF Value™: €14.60 vs. price of €11.81 (19.1% below fair value)
Industry Position: 83.3% above the Medical Devices & Instruments median (#359 of 816)
No single metric tells the full story. See the WBO:AVTR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
58GF Score
Get the complete analysis for WBO:AVTR
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:AVTR has been successfully added to your 
